Director Michael Pope Sells 15,702 Shares of Dave Inc (DAVE)
On June 11, 2024, Michael Pope, Director at Dave Inc (NASDAQ:DAVE), executed a sale of 15,702 shares of the company.
Source: yahoo.com
📰 Dave Inc News
Dave Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dave Inc. Real-time updates on events, politics, business and more.
Monday's stocks to buy include Apple, Nvidia, Tesla, Shopify and more
Here are the biggest calls on Wall Street on Monday.
Source: cnbc.com
Stocks making the biggest moves midday: TSLA, ROKU, AAPL, DPZ
These are the stocks posting the largest moves in midday trading.
Source: cnbc.com
Short Interest in Dave Inc. (NASDAQ:DAVEW) Declines By 51.0%
Dave Inc. (NASDAQ:DAVEW – Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 4,900 shares, a decline of 51.0% from the January 31st total of 10,000 shares. Based on an average trading volume of 34,200 shares, the […]
Source: modernreaders.com
Dave's Repurchase of FTX Convertible Note for $71 Million Finalized
/PRNewswire/ -- Dave Inc. ("Dave" or the "Company") (Nasdaq: DAVE), one of the nations leading neobanks, today announced the closing of its transaction with...
Source: prnewswire.com
Dave Buys Back Note From FTX - Los Angeles Business Journal
The digital banking service Dave Inc. recently tied up loose ends with its former investor FTX Ventures, the venture arm of the failed cryptocurrency exchange FTX.
Source: labusinessjournal.com
Dave Inc.'s (NASDAQ:DAVE) market cap up US$26m last week, benefiting both retail investors who own 41% as well as insiders
Key Insights The considerable ownership by retail investors in Dave indicates that they collectively have a greater say...
Source: yahoo.com
Insiders Buying Dave And 2 Other Stocks - Dave (NASDAQ:DAVE), EyePoint Pharmaceuticals (NASDAQ:EYPT)
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.
Robert Duggan Yadin Rozov Dave Inc Cormorant Global Healthcare Master Fund Eyepoint Pharmaceuticals Eyepoint Pharmaceuticals Inc
Source: benzinga.com